Overview
NCS Multistage Q2 revenue rises 23% yr/yr, beating analyst expectations
Net income for Q2 aided by $1.4 mln tax valuation release in Canada
Co acquires Reservoir Metrics, expanding tracer diagnostics service line
Outlook
Company remains cautiously optimistic for second half of 2025
NCS expects market conditions to deteriorate with U.S. rig count declines
Company sees potential oil market oversupply in late 2025
NCS cites ongoing uncertainties related to tariffs and trade
Result Drivers
FRACTURING SYSTEMS - Increased fracturing systems activity and frac plug sales in Canada and the U.S. drove revenue growth
INTERNATIONAL REVENUE - Decrease in tracer diagnostics activity in Middle East offset by higher sales in North Sea
ACQUISITION - Acquisition of Reservoir Metrics expected to complement tracer diagnostics offerings
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Beat | $36.50 mln | $27.70 mln (2 Analysts) |
Q2 Adjusted EBITDA | $2.20 mln |
Analyst Coverage
The one available analyst rating on the shares is "strong buy"
The average consensus recommendation for the oil related services and equipment peer group is "buy."
Wall Street's median 12-month price target for NCS Multistage Holdings Inc is $38.50, about 22% above its July 30 closing price of $30.04
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 17 three months ago
Press Release: ID:nGNX2gKf9v
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.